Gillette
This article was originally published in The Tan Sheet
Executive Summary
President & Chief Operating Officer Edward DeGrann, 57, assumes helm as acting CEO following resignation of Michael Hawley, Chairman Warren Buffett announces during analyst conference call Oct. 19. DeGrann, a 32-year Gillette veteran, is a likely candidate for the permanent spot, although his brief two-month tenure as president may lead to board reservations. Boston firm is conducting an extensive internal and external search for other candidates. The next CEO will face the challenge of reversing Gillette's recent quarterly sales declines and four years of underperforming stock prices
You may also be interested in...
Supplement GMP Warning Letters Make Modest Debut In 2010
Finalization of a settlement between the Federal Trade Commission and Rexall Sundown regarding unsupported cellulite treatment claims for the firm's Cellasene dietary supplement hinges upon approval of two related class action settlements pending in California and Florida, according to FTC
In Brief
Combe sells most of its OTC brands
People In Brief
Perrigo promotes in pricing, planning